Correctional Health Services, BC Mental Health and Substance Use Services, Provincial Health Services Authority, British Columbia, Canada.
Department of Psychiatry, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia, Canada.
J Correct Health Care. 2022 Dec;28(6):368-371. doi: 10.1089/jchc.21.07.0063. Epub 2022 Nov 7.
Incarcerated clients experience high rates of opioid use disorder and overdose. It is critical that opioid agonist treatment (OAT) is provided in correctional facilities. However, few receive OAT due to concerns about diversion, misuse, and safety. Buprenorphine extended-release (BUP-XR), a monthly buprenorphine depot injection, could be especially advantageous in the correctional setting as it can prevent diversion and misuse, saving staff resources and time. An injection of BUP-XR is costly compared with a monthly supply of buprenorphine/naloxone (BUP/NX) tablets. We demonstrate that when factoring in the added costs of medication preparation, administration, monitoring, and personnel, it is more economical to provide BUP-XR than BUP/NX. Other facilities, by utilizing our cost breakdown, can determine whether BUP-XR is economically advantageous at their own facility.
被监禁的人滥用阿片类药物的比例和过量用药的比例都很高。在监狱提供阿片类激动剂治疗（OAT）是至关重要的。然而，由于担心药物转移、滥用和安全问题，很少有人接受 OAT。丁丙诺啡缓释剂（BUP-XR），一种每月一次的丁丙诺啡储库注射剂，在监狱环境中可能特别有利，因为它可以防止药物转移和滥用，节省工作人员的资源和时间。与每月供应的丁丙诺啡/纳洛酮（BUP/NX）片剂相比，BUP-XR 的注射费用更高。我们证明，在考虑药物准备、管理、监测和人员的额外成本后，提供 BUP-XR 比提供 BUP/NX 更经济。其他机构可以根据我们的成本细分，确定 BUP-XR 在其机构是否具有经济优势。
